Techniker Krankenkasse (TK) has signed new generics rebate agreements for 17 active ingredients whose patents have expired. The agreements are valid for two years from April 1, 2012.
Rebate agreements were saving TK up to 200 million Euro per year, said Professor Dr. Norbert Klusen, chairman at the board of TK. Altogether, TK has rebate agreements for more than 200 generic active ingredients with over 70 pharmaceutical companies.
[ilink url=“http://www.tk.de/tk/pressemitteilungen/politik/448620″] link to source (Techniker Krankenkasse)[/ilink]